Cary Street Partners Investment Advisory’s Sanofi SNY Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,929	Closed	-$226K	–	720
2024 Q3	$226K	Sell	3,929 -1,144	-23%	-$61.8K	0.01%	694
2024 Q2	$246K	Buy	+5,073	New	+$245K	0.01%	657
2023 Q4	–	Sell	-3,089	Closed	-$166K	–	1642
2023 Q3	$166K	Buy	3,089 +135	+5%	+$7.2K	0.01%	594
2023 Q2	$159K	Sell	2,954 -195	-6%	-$10.5K	0.01%	568
2023 Q1	$171K	Buy	3,149 +653	+26%	+$31.8K	0.01%	499
2022 Q4	$121K	Buy	+2,496	New	+$110K	0.01%	557
2022 Q3	–	Sell	-3,168	Closed	-$158K	–	561
2022 Q2	$158K	Buy	+3,168	New	+$168K	0.01%	457
2020 Q4	–	Sell	-316	Closed	-$16K	–	785
2020 Q3	$16K	Buy	+316	New	+$16.3K	﹤0.01%	695

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cary Street Partners Investment Advisory's SNY Position: Q4 2024 in Review

Cary Street Partners Investment Advisory sold out of Sanofi (SNY) in Q4 2024, closing a stake of 3,929 shares — an estimated $226K sold.

Cary Street Partners Investment Advisory first reported a position in SNY in Q3 2020 and held it in 8 quarters. The position peaked at $246K in Q2 2024. 732 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

Cary Street Partners Investment Advisory reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 3,929 Sanofi shares in Q4 2024, an estimated $226K.
Cary Street Partners Investment Advisory first reported a position in Sanofi in Q3 2020 and held it in 8 quarters.
Cary Street Partners Investment Advisory's Sanofi position peaked at $246K in Q2 2024.
732 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2024, filed 14 Feb 2025.